Treatment of Acute Renal Failure and Chronic Renal Insufficiency with Additional Trasylol Therapy
Despite improved dialysis techniques, in combination with balanced infusion therapy, early regulation of the water, electrolyte and acid/base metabolism and specific antibiotic therapy, acute renal failure, (ARF) has 29–69 % mortality rates. During the last 1 1/2 years, patients in ARF received in addition to the mentioned standard therapy, Trasylol by continuous drip infusion of usually 1 million KIU in 24 hours. Trasylol inhibits besides trypsin, chymotrypsin, plasmin and the kallikreins which are responsible for the liberation of kinin, as well as leukocytic lysosomal proteinases; these enzyme systems are mainly held responsible for the tubular damage to the kidneys, and in conjunction with oxygen deficiency and other noxae such as bacterial toxins, endogenous poisons and bilirubin, they induce ARF.
KeywordsAcute Renal Failur Chronic Renal Insufficiency Urinary Tract Obstruction Chronic Pyelonephritis Corrosive Sublimate
Unable to display preview. Download preview PDF.
- (1).Dittrich, P., H.J. Gurland, M. Kessel, M.A. Massini, E. Wetzels: Haemodialysis and Peritoneal Dialysis. Pages 243, 272, and 277. Edited by E. Wetzels — Springer, Berlin-Heidelberg-New York, 1969.Google Scholar
- (2).Braun, I.: for Prognosis of Acute Renal Insufficiency. IN: Peter v. Dittrich and Klaus F. Kopp: Actual Problems involved with Dialysis Procedures and Renal Insufficiency. Pages 172, 174 and 177. II. Symposium Innsbruck, 1967. Priedberg, 1968.Google Scholar
- (3).Hoeltzenbein, J.: The Artificial Kidney. Pages 212, 213, and 214. Edited by P. Enke, Stuttgart, 1969.Google Scholar
- (4).Braun, L.: The Acute Kidney Failure. Pages 3, 4, 5. Edited by P. Enke, Stuttgart, 1968.Google Scholar
- (5).Truss, P.: Medical World, 1968, pages 1845 — 1851.Google Scholar
- (6).Thurau, K.: The intrarenal roll of the Renin-Angiotensin system in the regulation of the Glomerulu-min filtrate and of sodium excretion. In: Actual Problems of Nephrology. Pages 75–87. IV. Symposium Saarbruecken and Homburg/Saar, 1965. Springer, Berlin-Heidelberg-New York, 1966.CrossRefGoogle Scholar
- (7).Back, N. and H. Wilkens: The Effects of Trasylol on Microcirculatory Phenomena. IN: G.L. Haberland and P. Matis: New Aspects of Trasylol Therapy, pages 61–73. Symposium Munich, 1968. Edited by Schattauer, Stuttgart-New York, 1969.Google Scholar
- (8).Werle, E.: To the Biochemistry of Trasylol. In: G.L. Haberland, P. Matis: New Aspects of Trasylol Therapy, pages 49-59. Symposium in Munich, 1968. Edited by Schattauer, Stuttgart-New York, 1969.Google Scholar